NCT03354117View on ClinicalTrials.gov

On Demand Contraception: Ulipristal Acetate Plus a COX-2 Inhibitor at Peak Fertility

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 15, 2018

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions
Contraception
Interventions
DRUG

Ulipristal Acetate 30 MG Oral Tablet

Each study participant will receive one dose of the study medication (ulipristal acetate 30mg plus meloxicam 15mg) at peak fertility in the treatment cycle.

Trial Locations (1)

94305

Stanford University, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT03354117 - On Demand Contraception: Ulipristal Acetate Plus a COX-2 Inhibitor at Peak Fertility | Biotech Hunter | Biotech Hunter